在土耳其的喘患者中实施书面喘行动计划:一个多中心,横截面,描述性研究
Kurtuluş Aksu1, Gürgün Tuğçe Vural Solak1, Pınar Mutlu2
1Division of Immunology and Allergy, Department of Chest Diseases, Ankara Atatürk Sanatorium Training and Research Hospital, University of Health Sciences, Ankara, Turkiye.
Turkish journal of medical sciences
|December 30, 2024
概括
在土耳其,喘行动计划很少被提供给患者,但那些接受这些计划的人会大受益. 提供书面喘行动计划对于改善患者的治疗结果和喘管理至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 过敏和免疫学 过敏和免疫学
- 公共卫生 公共卫生
背景情况:
- 关于在土耳其利用喘行动计划的数据有限.
- 了解患者的意识和遵守喘行动计划对于有效的喘管理至关重要.
研究的目的:
- 评估在土耳其的喘患病率,提供行动计划和患者益处.
- 评估成人喘患者对喘行动计划的认识水平.
主要方法:
- 一项涉及265名成人喘患者的多中心,横截面描述性研究.
- 收集的数据包括人口统计,喘病史,GINA控制评估和喘行动计划的经验.
- 进行了统计分析,以确定影响计划提供和收益的因素.
主要成果:
- 只有34.3%的患者被告知喘行动计划,93.4%受益于书面计划.
- 在80%的患者中,控制了喘.
- 文盲患者获得喘行动计划的比例明显较低.
结论:
- 在土耳其提供喘行动计划的比例很低,尽管对患者有很大的益处.
- 书面喘行动计划是改善喘管理的有效工具.
- 医疗保健提供者应优先为所有喘患者提供书面喘行动计划.
相关概念视频
Asthma-IV: Nursing Management
2.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
2.9K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Diagnostic and Management
2.4K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.4K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
131
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
131
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
Antiasthma Drugs: β2-Adrenoceptor Agonists
146
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
146


